99 related articles for article (PubMed ID: 21054139)
1. Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation.
Ma HI; Chiou SH; Hueng DY; Tai LK; Huang PI; Kao CL; Chen YW; Sytwu HK
J Neurosurg; 2011 Mar; 114(3):651-62. PubMed ID: 21054139
[TBL] [Abstract][Full Text] [Related]
2. CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell line HCT-116.
Dittfeld C; Dietrich A; Peickert S; Hering S; Baumann M; Grade M; Ried T; Kunz-Schughart LA
Radiother Oncol; 2010 Mar; 94(3):375-83. PubMed ID: 20344822
[TBL] [Abstract][Full Text] [Related]
3. N-cadherin upregulation mediates adaptive radioresistance in glioblastoma.
Osuka S; Zhu D; Zhang Z; Li C; Stackhouse CT; Sampetrean O; Olson JJ; Gillespie GY; Saya H; Willey CD; Van Meir EG
J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33720050
[TBL] [Abstract][Full Text] [Related]
4. Stress response of glioblastoma cells mediated by miR-17-5p targeting PTEN and the passenger strand miR-17-3p targeting MDM2.
Li H; Yang BB
Oncotarget; 2012 Dec; 3(12):1653-68. PubMed ID: 23391506
[TBL] [Abstract][Full Text] [Related]
5. Rapid re-expression of CD133 protein in colorectal cancer cell lines in vitro and in vivo.
Peickert S; Waurig J; Dittfeld C; Dietrich A; Garbe Y; Kabus L; Baumann M; Grade M; Ried T; Kunz-Schughart LA
Lab Invest; 2012 Nov; 92(11):1607-22. PubMed ID: 22964855
[TBL] [Abstract][Full Text] [Related]
6. The expression status of CD133 is associated with the pattern and timing of primary glioblastoma recurrence.
Shibahara I; Sonoda Y; Saito R; Kanamori M; Yamashita Y; Kumabe T; Watanabe M; Suzuki H; Watanabe T; Ishioka C; Tominaga T
Neuro Oncol; 2013 Sep; 15(9):1151-9. PubMed ID: 23658323
[TBL] [Abstract][Full Text] [Related]
7. Radiation Drives the Evolution of Orthotopic Xenografts Initiated from Glioblastoma Stem-like Cells.
McAbee JH; Rath BH; Valdez K; Young DL; Wu X; Shankavaram UT; Camphausen K; Tofilon PJ
Cancer Res; 2019 Dec; 79(23):6032-6043. PubMed ID: 31615806
[TBL] [Abstract][Full Text] [Related]
8. Repurposed Drugs Celecoxib and Fmoc-L-Leucine Alone and in Combination as Temozolomide-Resistant Antiglioma Agents-Comparative Studies on Normal and Immortalized Cell Lines, and on
Uram Ł; Pieńkowska N; Misiorek M; Szymaszek Ż; Twardowska M; Siorek M; Wołowiec S
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542198
[TBL] [Abstract][Full Text] [Related]
9. Metabolic reprogramming of glioblastoma cells by L-asparaginase sensitizes for apoptosis in vitro and in vivo.
Karpel-Massler G; Ramani D; Shu C; Halatsch ME; Westhoff MA; Bruce JN; Canoll P; Siegelin MD
Oncotarget; 2016 Jun; 7(23):33512-28. PubMed ID: 27172899
[TBL] [Abstract][Full Text] [Related]
10. COX-2 overexpression increases malignant potential of human glioma cells through Id1.
Xu K; Wang L; Shu HK
Oncotarget; 2014 Mar; 5(5):1241-52. PubMed ID: 24659686
[TBL] [Abstract][Full Text] [Related]
11. An Overview of CD133 as a Functional Unit of Prognosis and Treatment Resistance in Glioblastoma.
Joyce T; Jagasia S; Tasci E; Camphausen K; Krauze AV
Curr Oncol; 2023 Sep; 30(9):8278-8293. PubMed ID: 37754516
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cyclooxygenase-2 enhances immunotherapy against experimental brain tumors.
Eberstål S; Badn W; Fritzell S; Esbjörnsson M; Darabi A; Visse E; Siesjö P
Cancer Immunol Immunother; 2012 Aug; 61(8):1191-9. PubMed ID: 22213142
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral Delivery of Chimeric Antigen Receptor T Cells Targeting CD133 Effectively Treats Brain Metastases.
Kieliszek AM; Mobilio D; Upreti D; Bloemberg D; Escudero L; Kwiecien JM; Alizada Z; Zhai K; Ang P; Chafe SC; Vora P; Venugopal C; Singh SK
Clin Cancer Res; 2024 Feb; 30(3):554-563. PubMed ID: 37787999
[TBL] [Abstract][Full Text] [Related]
14. Impact of stromal sensitivity on radiation response of tumors implanted in SCID hosts revisited.
García-Barros M; Thin TH; Maj J; Cordon-Cardo C; Haimovitz-Friedman A; Fuks Z; Kolesnick R
Cancer Res; 2010 Oct; 70(20):8179-86. PubMed ID: 20924105
[TBL] [Abstract][Full Text] [Related]
15. Anti-cancer effect of low dose of celecoxib may be associated with lnc-SCD-1:13 and lnc-PTMS-1:3 but not COX-2 in NCI-N87 cells.
Song B; Shu ZB; Du J; Ren JC; Feng Y
Oncol Lett; 2017 Aug; 14(2):1775-1779. PubMed ID: 28789408
[TBL] [Abstract][Full Text] [Related]
16. Impact of Ferroptosis Inducers on Chronic Radiation-exposed Survivor Glioblastoma Cells.
Erdem İS
Anticancer Agents Med Chem; 2023; 23(19):2154-2160. PubMed ID: 37622695
[TBL] [Abstract][Full Text] [Related]
17. Increased seroreactivity to glioma-expressed antigen 2 in brain tumor patients under radiation.
Heisel SM; Ketter R; Keller A; Klein V; Pallasch CP; Lenhof HP; Meese E
PLoS One; 2008 May; 3(5):e2164. PubMed ID: 18478111
[TBL] [Abstract][Full Text] [Related]
18. Single-cell Western blotting after whole-cell imaging to assess cancer chemotherapeutic response.
Kang CC; Lin JM; Xu Z; Kumar S; Herr AE
Anal Chem; 2014 Oct; 86(20):10429-36. PubMed ID: 25226230
[TBL] [Abstract][Full Text] [Related]
19. Omeprazole Inhibits Glioblastoma Cell Invasion and Tumor Growth.
Jin UH; Michelhaugh SK; Polin LA; Shrestha R; Mittal S; Safe S
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32731514
[No Abstract] [Full Text] [Related]
20. HSP90B1-mediated plasma membrane localization of GLUT1 promotes radioresistance of glioblastomas.
Li Y; Ge Y; Zhao M; Ding F; Wang X; Shi Z; Ge X; Wang X; Qian X
J Biomed Res; 2023 Sep; 37(5):326-339. PubMed ID: 37750323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
